- Home
- AIRT vs NRXS Comparison
AIRT vs NRXS Comparison
Compare AIRT & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIRT | NRXS |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | United States | United States |
| Employees | 646 | N/A |
| Industry | Air Freight/Delivery Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.8M | 78.9M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | AIRT | NRXS |
|---|---|---|
| Price | $27.08 | $7.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 2.9K | ★ 77.0K |
| Earning Date | 02-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.13 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,569,282.00 |
| Revenue This Year | N/A | $172.91 |
| Revenue Next Year | N/A | $115.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.89 |
| 52 Week Low | $18.35 | $2.20 |
| 52 Week High | $34.49 | $9.33 |
Technical Indicators
Market Signals| Indicator | AIRT | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 51.47 |
| Support Level | $20.80 | $7.17 |
| Resistance Level | N/A | $7.79 |
| Average True Range (ATR) | 2.04 | 0.36 |
| MACD | 0.35 | 0.04 |
| Stochastic Oscillator | 47.58 | 59.59 |
Price Performance
Historical ComparisonAbout AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include overnight air cargo, ground support equipment, commercial aircraft, engines and parts, digital solutions, and regional airline. The company generates maximum revenue from the overnight air cargo segment.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).